Recombinant Legionella pneumophila subsp. pneumophila Elongation factor G (fusA), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we will prioritize shipping the format currently in stock, please specify your format preference in order remarks for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline for your preparations.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during manufacturing.
Tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
fusA; lpg0326; Elongation factor G; EF-G
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513)
Target Names
fusA
Uniprot No.

Target Background

Function
This protein catalyzes the GTP-dependent ribosomal translocation crucial for translational elongation. This process involves a ribosome transition from the pre-translocational (PRE) to the post-translocational (POST) state. During this shift, the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites respectively. The protein facilitates the coordinated movement of these tRNAs, mRNA, and the necessary conformational ribosome changes.
Database Links

KEGG: lpn:lpg0326

STRING: 272624.lpg0326

Protein Families
TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-G/EF-2 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Elongation Factor G (fusA) in L. pneumophila and what is its primary function?

Elongation factor G (EF-G), encoded by the fusA gene in Legionella pneumophila, is a GTPase that catalyzes the translocation step of protein synthesis. During this critical process, EF-G facilitates the coordinated movement of transfer RNAs (tRNAs) and messenger RNA (mRNA) by one codon within the ribosome . This translocation step is essential for the elongation phase of protein synthesis in prokaryotes.

The energy required for this mechanical work comes from GTP hydrolysis. Structurally, EF-G undergoes conformational changes during the translocation cycle, with distinct rotational movements of its domains relative to the ribosome . These structural dynamics are fundamental to EF-G's ability to catalyze rapid and precise translocation, ensuring the fidelity of protein synthesis in L. pneumophila.

How does L. pneumophila EF-G differ from other bacterial elongation factors?

L. pneumophila EF-G shares the core functional domains with other bacterial EF-G proteins, but possesses unique structural features that may contribute to its specific activity in this intracellular pathogen. Unlike EF-G from model organisms like E. coli, L. pneumophila EF-G functions within the context of a bacterial species that has evolved to invade and proliferate within eukaryotic host cells, including human alveolar macrophages .

Research using single-molecule polarized fluorescence microscopy has revealed that bacterial EF-G generally exhibits a small (approximately 10°) global rotational motion relative to the ribosome after GTP hydrolysis, which exerts force to unlock the ribosome . This is followed by a larger rotation within domain III before dissociation from the ribosome. These motions appear to be conserved features of bacterial elongation factors, though specific variations may exist in L. pneumophila EF-G that optimize its function within host cells.

What is the relationship between L. pneumophila's fusA gene and pathogenicity?

While the fusA gene itself has not been directly linked to L. pneumophila pathogenicity in the provided research, the protein synthesis machinery it supports is essential for bacterial survival and replication within host cells. L. pneumophila is known to multiply several hundred-fold within host cells before being released through induction of apoptosis or necrosis .

What are the optimal methods for expressing recombinant L. pneumophila EF-G in laboratory settings?

For expression of recombinant L. pneumophila EF-G, researchers typically employ bacterial expression systems based on E. coli. The recommended methodology includes:

  • Gene optimization and vector design: The L. pneumophila fusA gene sequence should be codon-optimized for the expression host. Inclusion of an N- or C-terminal affinity tag (such as 6xHis or GST) facilitates downstream purification.

  • Expression conditions: Optimal expression often requires lower temperatures (16-25°C) after induction to promote proper folding of this large GTPase protein.

  • Purification approach: A two-step purification protocol using affinity chromatography followed by size exclusion chromatography yields high-purity recombinant EF-G.

  • Quality control: Assess protein activity through GTPase assays and ribosome binding studies to confirm functional integrity.

Successful recombinant expression enables structural studies, biochemical characterization, and functional assays that can reveal the specific properties of L. pneumophila EF-G compared to other bacterial homologs.

How can researchers effectively study the structural dynamics of L. pneumophila EF-G during translocation?

Investigating the structural dynamics of L. pneumophila EF-G during translocation requires specialized techniques that capture the protein's movement on the ribosome. Based on current methodologies, researchers should consider:

  • Single-molecule polarized fluorescence microscopy: This technique has successfully captured the rotational motions of individual domains of EF-G during normal translocation . The approach involves fluorescent labeling of specific domains of EF-G and monitoring their orientation changes during the translocation cycle.

  • Cryo-electron microscopy (cryo-EM): For static snapshots of different conformational states, cryo-EM can visualize EF-G bound to the ribosome at various intermediate steps of translocation.

  • FRET-based approaches: Fluorescence resonance energy transfer between strategically placed fluorophores can monitor distance changes between domains during the translocation process.

  • Time-resolved structural studies: Combining rapid kinetic techniques with structural methods provides insights into the temporal sequence of conformational changes.

These approaches have revealed that EF-G exhibits specific rotational motions after GTP hydrolysis that contribute to ribosome unlocking and subsequent steps of translocation .

What methods are most effective for studying the interaction between L. pneumophila EF-G and host cell factors?

To study interactions between L. pneumophila EF-G and host cell factors, researchers should employ a multi-faceted approach:

  • Pull-down assays and co-immunoprecipitation: Using tagged recombinant EF-G to identify host proteins that interact with this bacterial factor.

  • Surface plasmon resonance (SPR) or bio-layer interferometry (BLI): For quantitative binding kinetics between purified EF-G and candidate host proteins.

  • Cellular infection models: Using human alveolar epithelial cells (such as A549) or macrophages infected with L. pneumophila strains with modified fusA genes to assess the impact on bacterial replication and host responses .

  • Proximity labeling approaches: Expressing EF-G fused to enzymes like BioID or APEX2 during infection to identify proximal host proteins in the native cellular context.

  • Fluorescence microscopy: Tracking the localization of EF-G during infection to determine if it accesses host cell compartments beyond the bacterial-containing vacuole.

Understanding these interactions may reveal whether L. pneumophila EF-G plays roles beyond its canonical function in bacterial protein synthesis, potentially contributing to host-pathogen interactions.

How might L. pneumophila EF-G contribute to the bacterium's ability to replicate within host cells?

L. pneumophila EF-G likely contributes to intracellular replication primarily through its essential role in bacterial protein synthesis. As an intracellular pathogen, L. pneumophila multiplies several hundred-fold within host cells before inducing cell death mechanisms for release and new infection cycles .

The efficient function of EF-G ensures robust protein synthesis capability, which is critical for:

  • Rapid replication: Supporting the production of all proteins needed for bacterial multiplication within specialized vacuoles inside host cells.

  • Virulence factor production: Enabling synthesis of various virulence proteins that modify host cell functions, including the Legionella glucosyltransferase that targets host elongation factor EF1A .

  • Stress adaptation: Facilitating the production of proteins needed to adapt to the intracellular environment and evade host defense mechanisms.

While EF-G itself may not be a classical virulence factor, its optimal function is likely prerequisite for the bacterium's ability to establish and maintain its replicative niche within host cells.

Is there evidence that L. pneumophila EF-G directly interacts with host cellular machinery?

This example of targeting host translation machinery suggests the possibility that other bacterial factors, potentially including EF-G, might interact with host components. Experimental approaches to investigate this possibility would include:

  • Protein-protein interaction studies between purified L. pneumophila EF-G and host cell lysates

  • Localization studies during infection to determine if EF-G is secreted into host cells

  • Comparative analysis of host responses to wild-type versus fusA-mutant L. pneumophila strains

Such studies would help determine whether L. pneumophila EF-G has evolved moonlighting functions beyond its canonical role in bacterial translation.

How does L. pneumophila's protein synthesis machinery, including EF-G, compare with other intracellular bacterial pathogens?

L. pneumophila's protein synthesis machinery, including EF-G, shares core features with other bacterial pathogens but may possess specialized adaptations for intracellular survival. Comparative analysis reveals:

  • Conservation of essential translation factors: Like other bacteria, L. pneumophila relies on EF-G for the translocation step of protein synthesis, with the core GTPase mechanism conserved across species .

  • Specialized adaptation for intracellular lifestyle: As an intracellular pathogen, L. pneumophila likely faces unique selective pressures on its translation machinery, potentially leading to optimizations for function within host cells.

  • Interaction with host translation: While L. pneumophila produces factors that target host elongation factors (specifically EF1A) , this strategy of disrupting host translation is shared with several other bacterial pathogens, suggesting convergent evolution of virulence strategies.

  • Horizontal gene transfer influence: Population genomic studies have revealed that L. pneumophila genomes show evidence of horizontal gene transfer for virulence factors , which may potentially extend to components of the translation machinery in some lineages.

Further comparative genomics and biochemical studies of translation factors across intracellular pathogens would help identify specific adaptations in L. pneumophila's protein synthesis machinery that might contribute to its particular niche as an opportunistic pathogen of amoebae and humans.

What structural features of L. pneumophila EF-G are critical for its function during translocation?

The functional activity of L. pneumophila EF-G during translocation depends on several key structural features:

  • GTPase domain: The N-terminal GTPase domain is essential for binding and hydrolyzing GTP, providing the energy for translocation. This domain undergoes conformational changes after GTP hydrolysis that are transmitted to other parts of the protein .

  • Domain III rotation: Research has revealed a significant rotation within domain III of EF-G before its dissociation from the ribosome, suggesting this domain plays a crucial role in the later stages of translocation .

  • Global rotational motion: EF-G exhibits a small (approximately 10°) global rotational motion relative to the ribosome after GTP hydrolysis, which exerts force to unlock the ribosome . This power stroke mechanism is fundamental to EF-G's catalytic function.

  • Domain interfaces: The interfaces between the multiple domains of EF-G are likely critical for transmitting conformational changes from the GTPase domain to the regions that interact directly with the ribosome and tRNAs.

Understanding these structural features provides insight into the molecular mechanism of EF-G-catalyzed translocation and may reveal potential targets for antimicrobial development.

How does GTP hydrolysis drive the conformational changes in L. pneumophila EF-G during translocation?

GTP hydrolysis drives a cascade of conformational changes in L. pneumophila EF-G that power the translocation process. Based on single-molecule studies of EF-G dynamics, the process follows this sequence:

  • Initial binding: EF-G- GTP binds to the pre-translocation (PRE) ribosomal complex in a conformation that allows it to interact with the ribosomal factors.

  • GTP hydrolysis: The GTPase activity of EF-G converts GTP to GDP + Pi, releasing energy that induces conformational changes in the protein.

  • Power stroke mechanism: Following GTP hydrolysis, EF-G undergoes a small (~10°) global rotational motion relative to the ribosome that exerts force to unlock the ribosome structure .

  • Domain rearrangements: This initial movement is followed by larger rotational motion within domain III of EF-G, which likely contributes to moving the tRNAs and mRNA through the ribosome .

  • Completion and release: After facilitating the movement of tRNAs and mRNA, EF-G in its GDP-bound form dissociates from the post-translocation (POST) ribosomal complex.

This coordinated series of structural changes represents a hybrid mechanistic model incorporating both power-stroke and Brownian-ratchet elements to ensure efficient and accurate translocation .

What computational approaches can predict functional regions and potential inhibitor binding sites in L. pneumophila EF-G?

Computational approaches offer powerful tools for predicting functional regions and potential inhibitor binding sites in L. pneumophila EF-G:

  • Homology modeling: Using resolved structures of EF-G from other bacterial species as templates to predict the three-dimensional structure of L. pneumophila EF-G.

  • Molecular dynamics simulations: These can reveal dynamic properties of EF-G, including conformational changes during the GTP hydrolysis cycle and interactions with the ribosome.

  • Conservation analysis: Mapping evolutionary conservation across the protein sequence identifies functionally important residues that may be critical for activity or species-specific functions.

  • Binding site prediction algorithms: Tools like SiteMap, FTMap, or CASTp can identify potential small molecule binding pockets that might be targeted by inhibitors.

  • Virtual screening: Once potential binding sites are identified, virtual screening of compound libraries can identify candidate molecules for experimental testing as EF-G inhibitors.

  • Machine learning approaches: Systems similar to FuSA (described for other applications) could potentially be adapted to analyze patterns in EF-G sequence, structure, and function data to identify critical features.

These computational approaches, combined with experimental validation, can accelerate the identification of functional motifs and potential therapeutic targets within L. pneumophila EF-G structure.

How can recombinant L. pneumophila EF-G be used to develop novel antibiotics targeting protein synthesis?

Recombinant L. pneumophila EF-G provides a valuable tool for developing novel antibiotics through several research approaches:

  • High-throughput screening platforms: Purified recombinant EF-G enables biochemical assays to screen for compounds that inhibit its GTPase activity or ribosome interaction.

  • Structure-based drug design: Solving the crystal structure of L. pneumophila EF-G, particularly in complex with GTP analogs or the ribosome, provides templates for rational design of inhibitors that target specific functional pockets.

  • Differential targeting strategy: Comparing the structures and biochemical properties of bacterial EF-G with the human mitochondrial homolog (mtEF-G) identifies bacterial-specific features that could be selectively targeted to minimize toxicity.

  • Translation assays: Reconstituted translation systems incorporating recombinant L. pneumophila EF-G allow testing of candidate inhibitors in a controlled environment before advancing to cell-based studies.

  • Resistance mechanism studies: Generating and characterizing resistant mutants of recombinant EF-G provides insight into potential resistance mechanisms, informing the design of more robust inhibitors or combination strategies.

Given the essential nature of protein synthesis for bacterial survival and the structural differences between bacterial and eukaryotic translation factors, EF-G remains an attractive target for developing new antibiotics against L. pneumophila and potentially other bacterial pathogens.

What role might EF-G play in the development of L. pneumophila resistance to existing antibiotics?

EF-G could potentially contribute to L. pneumophila antibiotic resistance through several mechanisms:

  • Target site modifications: Mutations in the fusA gene encoding EF-G might alter binding sites for antibiotics that target protein synthesis, such as fusidic acid, which specifically binds to EF-G and prevents its release from the ribosome.

  • Compensatory adaptations: When other components of the translation machinery are targeted by antibiotics, compensatory mutations in EF-G might restore protein synthesis efficiency despite the presence of the antibiotic.

  • Expression level changes: Altered expression of EF-G could potentially compensate for partial inhibition by antibiotics, contributing to resistance.

  • Horizontal gene transfer: Population studies of L. pneumophila have revealed extensive horizontal gene transfer of other resistance determinants , suggesting the possibility that variant fusA genes might similarly spread among strains.

Research approaches to investigate these possibilities include whole genome sequencing of resistant isolates, directed evolution experiments under antibiotic selection, and biochemical characterization of EF-G variants from resistant strains. Understanding these potential resistance mechanisms would inform both antibiotic development strategies and clinical treatment approaches.

How might the study of L. pneumophila EF-G contribute to understanding the evolution of bacterial translation systems?

Studying L. pneumophila EF-G offers valuable insights into the evolution of bacterial translation systems:

  • Adaptation to host environments: As an intracellular pathogen that replicates within diverse amoebae and human cells, L. pneumophila's translation machinery may reveal adaptations for functioning in these specialized niches.

  • Horizontal gene transfer influences: Population genomic analyses have demonstrated horizontal transfer of virulence factors across L. pneumophila lineages . Examining whether similar processes have shaped the evolution of translation factors like EF-G could reveal how core cellular machinery evolves in the context of pathogenesis.

  • Comparison with eukaryotic elongation factors: L. pneumophila interacts closely with eukaryotic hosts and targets host elongation factor EF1A . Studying its own EF-G may reveal co-evolutionary patterns or functional convergence with eukaryotic factors.

  • Molecular fossil record: As a core component of the translation machinery, EF-G is ancient and highly conserved. Variations in L. pneumophila EF-G compared to other bacteria may highlight specific selective pressures that have shaped this essential protein during the evolution of intracellular lifestyles.

These evolutionary insights may extend beyond L. pneumophila to inform our broader understanding of how essential cellular machinery adapts during the evolution of pathogenesis while maintaining its core functions.

What are the most promising future research directions for understanding L. pneumophila EF-G?

The most promising future research directions for understanding L. pneumophila EF-G include:

  • Structural characterization: Determining high-resolution structures of L. pneumophila EF-G in different conformational states, particularly in complex with the ribosome.

  • Mechanistic studies: Further investigating the power stroke mechanism and rotational dynamics during translocation using advanced single-molecule techniques .

  • Host-pathogen interaction focus: Exploring whether L. pneumophila EF-G has evolved interactions with host factors beyond its canonical role in bacterial translation.

  • Comparative genomics: Analyzing fusA sequence variations across clinical and environmental L. pneumophila isolates to identify potential adaptations related to virulence or environmental persistence.

  • Antimicrobial development: Using recombinant L. pneumophila EF-G to screen for and characterize novel inhibitors as potential therapeutics for Legionnaires' disease.

  • Systems biology approach: Integrating EF-G function into broader models of L. pneumophila metabolism and virulence to understand its contextual importance during infection.

These research directions would significantly advance our understanding of both the fundamental molecular mechanisms of bacterial protein synthesis and the specific adaptations that enable L. pneumophila's success as an opportunistic pathogen.

How does understanding L. pneumophila EF-G contribute to the broader field of bacterial pathogenesis?

Understanding L. pneumophila EF-G contributes to the broader field of bacterial pathogenesis in several important ways:

  • Basic mechanisms of essential processes: It provides insights into how core cellular machinery functions within the context of an intracellular pathogen, potentially revealing adaptations that support pathogenic lifestyles.

  • Virulence factor synthesis: EF-G is essential for the synthesis of virulence factors that modify host cell functions, such as the glucosyltransferase that targets host EF1A .

  • Therapeutic target potential: As an essential bacterial protein with structural differences from human homologs, EF-G represents a potential target for new antibiotics to treat Legionnaires' disease.

  • Evolutionary perspective: Studying L. pneumophila EF-G in the context of the bacterium's complex ecological niche (as both an environmental organism and human pathogen) provides insights into how core cellular components evolve during the adaptation to pathogenesis.

  • Methodological advances: Techniques developed to study L. pneumophila EF-G structure and function, such as single-molecule approaches to capture protein dynamics during translocation , can be applied to study other bacterial pathogens.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.